These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9067919)

  • 41. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
    Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
    Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I.
    Bohé J; Ding H; Qing DP; Yoon K; Hirschberg R; Wolfgang GH; Kopple JD
    Kidney Int; 1998 Oct; 54(4):1070-82. PubMed ID: 9767523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects.
    Grønbaek H; Flyvbjerg A; Winding P; Frystyk J; Hey H
    Growth Horm IGF Res; 2005 Aug; 15(4):243-50. PubMed ID: 15925526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Durham SK; Brewer ED; Frane JW; Watkins SL; Hogg RJ; Mohan S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):596-601. PubMed ID: 10022422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF.
    Hladunewich MA; Corrigan G; Derby GC; Ramaswamy D; Kambham N; Scandling JD; Myers BD
    Kidney Int; 2003 Aug; 64(2):593-602. PubMed ID: 12846755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of antimicrobials and weaning on porcine serum insulin-like growth factor binding protein levels.
    Hathaway MR; Dayton WR; White ME; Pampusch MS
    J Anim Sci; 2003 Jun; 81(6):1456-63. PubMed ID: 12817493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.
    Powell DR; Durham SK; Liu F; Baker BK; Lee PD; Watkins SL; Campbell PG; Brewer ED; Hintz RL; Hogg RJ
    J Clin Endocrinol Metab; 1998 May; 83(5):1654-61. PubMed ID: 9589673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.
    Ivarsen P; Chen JW; Tietze I; Christiansen JS; Flyvbjerg A; Frystyk J
    Growth Horm IGF Res; 2010 Apr; 20(2):156-61. PubMed ID: 20044291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
    Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
    Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.
    Ferry RJ; Cohen P; Levitt Katz LE
    Horm Res; 2005; 63(5):220-7. PubMed ID: 15886488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum.
    Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR
    Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired postprandial regulation of insulin-like growth factor binding protein-1 in children with chronic renal failure.
    Haffner D; Blum WF; Heinrich U; Mehls O; Tönshoff B
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2832-5. PubMed ID: 9284705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study.
    Argüelles B; Barrios V; Pozo J; Muñoz MT; Argente J
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.